$0.650
-0.0015 (-0.230%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX).
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
01:09pm, Monday, 03'rd Mar 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options
Lost Money on Cardlytics, Inc. (CDLX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
10:30am, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws
NEW YORK CITY, NY / ACCESS Newswire / March 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardly
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics, Inc. Lawsuit - CDLX
05:45am, Monday, 03'rd Mar 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class
Investors who lost money on Cardlytics, Inc.(CDLX) should contact Levi & Korsinsky about pending Class Action - CDLX
11:13am, Sunday, 02'nd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 2, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytic
Shareholders that lost money on Cardlytics, Inc.(CDLX) should contact Levi & Korsinsky about pending Class Action - CDLX
10:13am, Sunday, 02'nd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 2, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws
NEW YORK CITY, NY / ACCESS Newswire / March 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardly
Cardlytics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - CDLX
06:02pm, Saturday, 01'st Mar 2025
NEW YORK, NY / ACCESS Newswire / March 1, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Cardlytics, Inc.
11:00am, Saturday, 01'st Mar 2025
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytic
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 28'th Feb 2025
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on February 26, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 225,800 restri
Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join - Contact Levi & Korsinsky
02:30pm, Friday, 28'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities
Sign In
Buy CDLX